TRANSITION CONTRACT MANUFACTURING AGREEMENT BY AND AMONG 3M COMPANY, GARDEN SPINCO CORPORATION AND NEOGEN CORPORATION DATED AS OF SEPTEMBER 1, 2022Transition Contract Manufacturing Agreement • September 1st, 2022 • Neogen Corp • In vitro & in vivo diagnostic substances • Delaware
This TRANSITION CONTRACT MANUFACTURING AGREEMENT (this “Agreement” or “TCMA”), dated as of September 1, 2022, (the “Effective Date”), is entered into by and among 3M Company, a Delaware corporation (“Supplier”), Garden SpinCo Corporation, a Delaware corporation (“SpinCo”), and Neogen Corporation, a Michigan corporation (“Customer” and, together with Supplier, the “Parties” and each, individually, a “Party”).
TRANSITION CONTRACT MANUFACTURING AGREEMENT BY AND BETWEEN 3M COMPANY AND SOLVENTUM CORPORATION DATED AS OF MARCH 31, 2024Transition Contract Manufacturing Agreement • April 4th, 2024 • Solventum Corp • Surgical & medical instruments & apparatus
Confidential Treatment Requested by 3M Health Care Company Pursuant to 17 C.F.R. Section 200.83 TRANSITION CONTRACT MANUFACTURING AGREEMENT BY AND BETWEEN [3M COMPANY] AND [3M HEALTH CARE COMPANY] DATED AS OFTransition Contract Manufacturing Agreement • January 26th, 2024 • 3M Health Care Co • Surgical & medical instruments & apparatus
